At the request of Sage and the Journal Editor, the following article has been retracted:
Ma Y, Bian C, Song D, Yao G, Nie R. 3,4-Methylenedioxymethamphetamine causes retinal damage in C57BL/6J mice. Human & Experimental Toxicology. 2020; 39(11): 1556–1564. doi:10.1177/0960327120930253
The corresponding author reached out to the Journal Editor, requesting to retract the article due to undisclosed conflict of interest associated with one of the co-authors. The authors have not provided further details.
An investigation by the Publisher revealed that this article may have been linked to an unauthorized third party.
Due to concerns around undisclosed conflict of interest as well as concerns around potential unauthorized third-party
involvement and the integrity of the published data, the Journal Editor retracts this article.
The authors agreed with the retraction.
References
1.
HooGW. The agony with ecstasy: lessons from a recent rave. J Intensive Care Med2013; 28: 259–261.
2.
CapelaJPCarmoHRemiaoF, et al.Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol Neurobiol2009; 39: 210–271.
3.
GowingLRHenry-EdwardsSMIrvineRJ, et al.The health effects of ecstasy: a literature review. Drug Alcohol Rev2002; 21: 53–63.
4.
ZsillaGHegyiDEBaranyiM, et al.3,4-Methylenedioxymethamphetamine, mephedrone, and β-phenylethylamine release dopamine from the cytoplasm by means of transporters and keep the concentration high and constant by blocking reuptake. Eur J Pharmacol2018; 837: 72–80.
5.
McCannUDSzaboZVranesicM, et al.Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methylenedioxymethamphetamine (“ecstasy”) users: relationship to cognitive performance. Psychopharmacology2008; 200: 439–450.
6.
YuFKamadaHNiizumaK, et al.Induction of MMP-9 expression and endothelial injury by oxidative stress after spinal cord injury. J Neurotrauma2008; 25: 184–195.
7.
KamadaHYuFNitoC, et al.Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood–brain barrier dysfunction. Stroke2007; 38: 1044–1049.
8.
Pérez-HernándezMFernández-ValleMERubio-AraizA, et al.3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus. Neuropharmacology2017; 118: 157–166.
9.
MirandaMBosch-MorellFJohnsen-SorianoS, et al.Oxidative stress in rat retina and hippocampus after chronic MDMA (“ecstasy”) administration. Neurochem Res2007; 32: 1156–1162.
10.
HassanLCarvalhoCYannuzziLA, et al.Central serous chorioretinopathy in a patient using methylenedioxymethamphetamine (MDMA) or “ecstasy”. Retina 2001; 21: 559–561.
11.
KesbyJPChangAMarkouA, et al.Modeling human methamphetamine use patterns in mice: chronic and binge methamphetamine exposure, reward function and neurochemistry. Addict Biol2018; 23: 206–218.
12.
De La GarzaRFabrizioKRGuptaA. Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns. Psychopharmacology2007; 189: 425–434.
13.
CarvalhoMCarmoHCostaVM, et al.Toxicity of amphetamines: an update. Arch Toxicol2012; 86: 1167–1231.
14.
ChoAKMelegaWP. Patterns of methamphetamine abuse and their consequences. J Addict Dis2002; 21: 21–34.
15.
SommersIBaskinDBaskin-SommersA. Methamphetamine use among young adults: health and social consequences. Addict Behav2006; 31: 1469–1476.
16.
PintoLHInvergoBShimomuraK, et al.Interpretation of the mouse electroretinogram. Doc Ophthalmol2007; 115: 127–136.
17.
SoloveiIKreysingMLanctotC, et al.Nuclear architecture of rod photoreceptor cells adapts to vision in mammalian evolution. Cell2009; 137: 356–368.
18.
OstrowskiSKasielskiMKordiakJ, et al.Myocardial oxidative stress in patients with active infective endocarditis. Int J Cardiol2013; 167: 270–276.
19.
LeunerKPantelJFreyC, et al.Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer’s disease. J Neural Transm Suppl2007; 72: 207–215.
20.
HernandezHRobertsALMcDowellCM. Nuclear factor-kappa beta signaling is required for transforming growth factor beta-2 induced ocular hypertension. Exp Eye Res2020; 191: 107920.
21.
LawrenceT. The nuclear factor NF-κB pathway in inflammation. Cold Spring Harb Perspect Biol2009; 1: a001651.
22.
YangYEstradaEYThompsonJF, et al.Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab2007; 27: 697–709.
23.
RobbinsTWEverittBJ. Drug addiction: bad habits add up. Nature1999; 398: 567–570.
24.
RenemanL. Designer drugs: How dangerous are they?J Neural Transm2003; 66: 61–83.
25.
SchmidtCJ. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther1987; 240: 1–7.
26.
KalantH. The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs. CMAJ2001; 165: 7.
27.
Montiel-DuarteCAnsorenaELópez-ZabalzaMJ, et al.Role of reactive oxygen species, glutathione and NF-kappaB in apoptosis induced by 3,4-methylenedioxymethamphetamine (“ecstasy”) on hepatic stellate cells. Biochem Pharmacol2004; 67: 1025–1033.
28.
CadetJLThirietNJayanthiS. Involvement of free radicals in MDMA-induced neurotoxicity in mice. Ann Med Interne2001; 152: 57–59.
29.
JayanthiSLadenheimBAndrewsAM, et al.Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (ecstasy). Neuroscience1999; 91: 1379–1387.
30.
LiuXYeH. Long-term treatment with 3,4-methylenedioxymethamphetamine caused retina damage in C57BL/6 mice. Arq Bras Oftalmol2019; 82: 363–371.
31.
CzlonkowskaAKurkowska-JastrzebskaI. Inflammation and gliosis in neurological diseases-clinical implications. J Neuroimmunol2011; 231: 78–85.
32.
ZouJYCrewsFT. TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res2005; 1034: 11–24.
33.
AltmannCSchmidtMHH. The role of microglia in diabetic retinopathy: inflammation, microvasculature defects and neurodegeneration. Int J Mol Sci2018; 19: E110.
34.
MelchiorriCMeliconiRFrizzieroL, et al.Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum1998; 41: 2165–2174.
35.
GoldringSRGoldringMB. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res2004: 427: S27–S36.
36.
OnyangoIGKhanSM. Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer’s disease. Curr Alzheimer Res2006; 3: 339–349.
37.
KongYNaqqertJKNishinaPM. The impact of Adherens and tight junctions on physiological function and pathological changes in the retina. Adv Exp Med Biol2018; 1074: 545–551.
38.
BehzadianMAWangXLWindsorLJ, et al.TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function. Invest Ophthalmol Vis Sci2001; 42: 853–859.
39.
KowluruRAMohammadGdos SantosJM, et al.Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage. Diabetes2011; 60: 3023–3033.
40.
DhandaSSandhirR. Blood–brain barrier permeability is exacerbated in experimental model of hepatic encephalopathy via MMP-9 activation and downregulation of tight junction proteins. Mol Neurobiol2018; 55: 3642–3659.
